Suppr超能文献

清除CD4+和CD8+ T细胞而非B细胞可消除炎症并延长TGFβ1缺陷小鼠的生存期。

Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.

作者信息

Bommireddy Ramireddy, Engle Sandra J, Ormsby Ilona, Boivin Gregory P, Babcock George F, Doetschman Thomas

机构信息

Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

出版信息

Cell Immunol. 2004 Nov-Dec;232(1-2):96-104. doi: 10.1016/j.cellimm.2005.02.004. Epub 2005 Mar 29.

Abstract

Transforming growth factor beta1 (TGFbeta1) is a potent negative immunoregulatory molecule. We have previously shown that the autoimmune-mediated weaning-age lethality of Tgfb1-/- mice is reversed upon genetic combination with Scid or Rag null alleles. Here, we show that elimination of T but not B cells is sufficient for the reversal, but elimination of either CD4+ or CD8+ cells is not. Although elimination of B cells does not rescue TGFbeta1-deficient animals from autoimmunity, B cells are hyperresponsive to LPS in the absence of TGFbeta1. TGFbeta1 deficiency leads to activation of CD8+ T cells as suggested by down-modulation of CD8 even in the absence of CD4+ T cells. This study provides evidence that both CD4+ and CD8+ T cells, but not B cells, have the ability to cause inflammation in the absence of TGFbeta1. However, though TGFbeta1-deficient B cells are hyperresponsive to stimulation, alone they are not sufficient to cause inflammation.

摘要

转化生长因子β1(TGFβ1)是一种强大的负性免疫调节分子。我们之前已经表明,Tgfb1-/-小鼠因自身免疫介导的断奶期致死性在与Scid或Rag无效等位基因进行基因组合后会得到逆转。在此,我们表明消除T细胞而非B细胞足以实现这种逆转,但消除CD4+或CD8+细胞则不行。虽然消除B细胞不能使TGFβ1缺陷动物免于自身免疫,但在缺乏TGFβ1的情况下,B细胞对脂多糖(LPS)反应过度。即使在没有CD4+ T细胞的情况下,CD8的下调也表明TGFβ1缺陷会导致CD8+ T细胞活化。这项研究提供了证据,表明在缺乏TGFβ1的情况下,CD4+和CD8+ T细胞都有引发炎症的能力,而B细胞则没有。然而,尽管TGFβ1缺陷的B细胞对刺激反应过度,但仅靠它们不足以引发炎症。

相似文献

引用本文的文献

2
Cytokine-mediated immunomodulation of osteoclastogenesis.细胞因子介导的破骨细胞生成免疫调节。
Bone. 2022 Nov;164:116540. doi: 10.1016/j.bone.2022.116540. Epub 2022 Aug 27.
9
TGFbeta1 and Treg cells: alliance for tolerance.转化生长因子β1与调节性T细胞:耐受性联盟
Trends Mol Med. 2007 Nov;13(11):492-501. doi: 10.1016/j.molmed.2007.08.005. Epub 2007 Oct 30.

本文引用的文献

4
TGF-beta, T-cell tolerance and anti-CD3 therapy.转化生长因子-β、T细胞耐受性与抗CD3疗法
Trends Mol Med. 2004 Jan;10(1):3-9. doi: 10.1016/j.molmed.2003.11.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验